These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22475489)

  • 21. Light-controlled toxicity of engineered amyloid β-peptides.
    Hoppmann C; Barucker C; Lorenz D; Multhaup G; Beyermann M
    Chembiochem; 2012 Dec; 13(18):2657-60. PubMed ID: 23161824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A peptide probe for detection of various beta-amyloid oligomers.
    Hu Y; Su B; Zheng H; Kim JR
    Mol Biosyst; 2012 Oct; 8(10):2741-52. PubMed ID: 22832997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of amyloid Aβ(1-42) peptide with self-assembled peptide nanospheres.
    Smoak EM; Dabakis MP; Henricus MM; Tamayev R; Banerjee IA
    J Pept Sci; 2011 Jan; 17(1):14-23. PubMed ID: 20814889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detergent-like interaction of Congo red with the amyloid beta peptide.
    Lendel C; Bolognesi B; Wahlström A; Dobson CM; Gräslund A
    Biochemistry; 2010 Feb; 49(7):1358-60. PubMed ID: 20070125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells.
    Hossain S; Hashimoto M; Katakura M; Miwa K; Shimada T; Shido O
    J Neurochem; 2009 Oct; 111(2):568-79. PubMed ID: 19686246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: Abeta association kinetics at endosomal pH.
    Gorman PM; Yip CM; Fraser PE; Chakrabartty A
    J Mol Biol; 2003 Jan; 325(4):743-57. PubMed ID: 12507477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A carboxylated Zn-phthalocyanine inhibits fibril formation of Alzheimer's amyloid β peptide.
    Tabassum S; Sheikh AM; Yano S; Ikeue T; Handa M; Nagai A
    FEBS J; 2015 Feb; 282(3):463-76. PubMed ID: 25404240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity.
    Giuffrida ML; Grasso G; Ruvo M; Pedone C; Saporito A; Marasco D; Pignataro B; Cascio C; Copani A; Rizzarelli E
    J Neurosci Res; 2007 Feb; 85(3):623-33. PubMed ID: 17131391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid.
    Kanapathipillai M; Lentzen G; Sierks M; Park CB
    FEBS Lett; 2005 Aug; 579(21):4775-80. PubMed ID: 16098972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface structure of amyloid-beta fibrils contributes to cytotoxicity.
    Yoshiike Y; Akagi T; Takashima A
    Biochemistry; 2007 Aug; 46(34):9805-12. PubMed ID: 17676931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A beta-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid beta-peptide.
    Castelletto V; Hamley IW; Lim T; De Tullio MB; Castaño EM
    J Pept Sci; 2010 Sep; 16(9):443-50. PubMed ID: 20648477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
    Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-Time Monitoring of Alzheimer's-Related Amyloid Aggregation via Probe Enhancement-Fluorescence Correlation Spectroscopy.
    Guan Y; Cao KJ; Cantlon A; Elbel K; Theodorakis EA; Walsh DM; Yang J; Shah JV
    ACS Chem Neurosci; 2015 Sep; 6(9):1503-8. PubMed ID: 26212450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.
    Saraiva AM; Cardoso I; Saraiva MJ; Tauer K; Pereira MC; Coelho MA; Möhwald H; Brezesinski G
    Macromol Biosci; 2010 Oct; 10(10):1152-63. PubMed ID: 20480510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
    Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
    Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folding stability of amyloid-beta 40 monomer is an important determinant of the nucleation kinetics in fibrillization.
    Ni CL; Shi HP; Yu HM; Chang YC; Chen YR
    FASEB J; 2011 Apr; 25(4):1390-401. PubMed ID: 21209058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.